SCIENTIFIC REPORT 2004 - Sylvester Comprehensive Cancer Center
SCIENTIFIC REPORT 2004 - Sylvester Comprehensive Cancer Center
SCIENTIFIC REPORT 2004 - Sylvester Comprehensive Cancer Center
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
C L I N I C A L O N C O L O G Y R E S E A R C H P R O G R A M<br />
the ER protein half-life was reduced in ERbreast<br />
cancer lines. These data support a model<br />
in which Her2 and cSrc cooperate with liganded<br />
ER to promote both ER dependent transcription<br />
and transcription linked ER proteolysis.<br />
SELECTED PUBLICATIONS<br />
2002<br />
Donovan, JC, Rothenstein, JM, and Slingerland,<br />
JM. Non-malignant and tumor-derived cells differ<br />
in their requirement for p27Kip1 in transforming<br />
growth factor-beta-mediated G1 arrest.<br />
Journal of Biological Chemistry 277:41686-92,<br />
2002.<br />
Lian, J, Zubovitz, J, Petrocelli, T, Kotchetkov, R,<br />
Connor, MK, Han, K, Lee, JH, Ciarallo, S,<br />
Catzavelos, C, Beniston R, Franssen, E, and<br />
Slingerland, JM . PKB/Akt phosphorylates p27,<br />
impairs nuclear import of p27 and opposes p27-<br />
mediated G1 arrest. Nature Medicine 8:1153-60,<br />
2002.<br />
Ciarallo, S, Subramaniam, V, Hung, W, Lee, JH,<br />
Kotchetkov, R, Sandhu, C, Milic, A, and<br />
Slingerland, JM . Altered p27(Kip1) phosphorylation,<br />
localization, and function in human epithelial<br />
cells resistant to transforming growth<br />
factor beta-mediated G(1) arrest. Molecular and<br />
Cellular Biology 22:2993-3002, 2002.<br />
2003<br />
Connor, MK, Kotchetkov, R, Cariou, S, Resch,<br />
A, Lupetti, R, Beniston, RG, Melchior, F,<br />
Hengst, L, and Slingerland, JM . CRM1/Ranmediated<br />
nuclear export of p27(Kip1) involves a<br />
nuclear export signal and links p27 export and<br />
proteolysis. Molecular Biology of the Cell<br />
14:201-13, 2003.<br />
Liang, J and Slingerland, JM . Multiple Roles of<br />
the PI3K/PKB (Akt) Pathway in cell cycle progression.<br />
Cell Cycle 2:339-45, 2003.<br />
MARK S. SOLOWAY, M.D.<br />
Professor and Chairman of Urology<br />
DESCRIPTION OF RESEARCH<br />
Much of the work in the University of<br />
Miami’s department of Urology is devoted<br />
to better understanding the role of surgery in<br />
treating prostate, bladder, and kidney cancers.<br />
The department has established a rather unique<br />
database of more than 1,300 men who have had<br />
radical prostatectomy performed by one surgeon<br />
and their pathology has been read by one pathologist.<br />
Through the efforts of devoted researchers,<br />
they have reported on the relationship<br />
between a number of clinical and pathologic risk<br />
factors, e.g., positive surgical margin location,<br />
seminal vesicle invasion, and risk of relapse. This<br />
is critical when counseling patients regarding diagnosis,<br />
follow-up schedule and, most importantly,<br />
the need and type of additional treatment.<br />
Researchers in Dr. Soloway’s laboratory have<br />
introduced the concept of local anesthesia for<br />
prostate biopsies. This has the potential to benefit<br />
more than 500,000 men annually in the United<br />
States who undergo this otherwise rather painful<br />
procedure. More than 13 randomized studies<br />
confirm the researchers’ observation of the benefit<br />
of a periprostatic nerve block prior to ultrasound<br />
guided prostate biopsies.<br />
In an effort to minimize the morbidity of<br />
radical retropubic prostatectomy, Dr. Soloway has<br />
taken steps to enhance recovery without sacrificing<br />
cancer control. To this end, he has reported<br />
his results with nerve sparing, the omission of a<br />
pelvic drain, and the use of a cell saver to obviate<br />
the need for an allogeneic transfusion.<br />
In collaboration with Gaetano Ciancio,<br />
M.D., professor of Surgery and Urology, they<br />
have carefully detailed their surgical approach to<br />
large kidney tumors. They have adapted techniques<br />
developed for liver transplantation to reduce<br />
the morbidity and mortality related to<br />
surgery of large renal tumors, many of which involve<br />
extension into the vena cava.<br />
UM/<strong>Sylvester</strong> <strong>Comprehensive</strong> <strong>Cancer</strong> <strong>Center</strong> Scientific Report <strong>2004</strong> 59